Brief: Starling Oncology Q2 EPS USD -0.08
06/08/2026 21:15
BRIEF-Starling Oncology Q2 EPS USD -0.08 Aug 06 (Reuters) - Starling Oncology Q2 net income USD -9.8 million.
- Q2 gross profit USD 27.2 million
Recent news on Starling Oncology
See all newsBrief: Starling Oncology Unit Enters Credit Agreement On August 20
Brief: Starling Oncology Q2 EPS USD -0.08
Brief: Oncology Institute Rebrands As Starling Oncology
Oncology Institute Q1 revenue rises on specialty pharmacy growth, reaffirms 2026 revenue guidance
Brief: Oncology Institute Q1 Gross Profit USD 23.3 Million